Commercial Channels

It marks the first time that two accrediting organizations with deeming authority from CMS have merged

Plan is to expand capabilities across the drug commercialization process

EnlivenHealth, formerly Population Health Solutions, targets better patient outcomes through advanced technology

'Contextual' AI blends human expertise and computer power

A modularized approach will enable pharma marketers to grow patient starts and improve adherence

Proteus Digital Health, a pioneer, crashes and burns, while EtectRx appoints a new CEO

More complex sales cycles, combined with more digitization of the sales process, calls for better engagement tools

Addressing continued hurdles in patient adherence

Company will invest $1 billion to open 500-700 clinics at its pharmacies over five years

Ed Schoonveld’s compilation on pricing strategies gets updated for the 2020s

Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges

Company pitches a mfr-payer-provider-patient collaboration for drug pricing

Trinity Life Sciences offers a way to measure changing physician practices during the pandemic

Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction

Position highlights the move toward more at-home services

Use of an eBV system can save months of re-verification work and >$100,000 in operational costs

Pharma marketing will have to adjust to a new reality

The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions

Reasons for, and actions to take, when switching hub service providers

Acquisition of Cumberland Life Sciences boosts its client base and range of services

Hub service providers look to telehealth to expand patient connectivity

Commercial teams can prepare for overcoming predictable hurdles

When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies

For sessions with co-workers or clients, consider these recommendations

US list-price sales reached $510 billion in 2019